What Your APOE Gene Has to Do With What You Eat in Perimenopause

Most nutrition advice for brain health treats all women the same. Eat more oily fish. Reduce ultra-processed foods. Add more vegetables. All of it is correct, and none of it is the whole picture.

A study published in JAMA Network Open in March 2026 by Norgren and colleagues found something that complicates the standard narrative considerably: the relationship between meat consumption and cognitive health was not uniform across the study population. It differed significantly — and consistently — based on a single gene variant. The APOE gene. And the findings have direct implications for how women in perimenopause think about protein, cognition, and personalised nutrition.

What is the APOE gene?

Apolipoprotein E (APOE) is a protein that plays a central role in lipid transport — moving cholesterol and other fats through the bloodstream and into cells, including neurons. The gene that encodes it exists in three common variants: APOE2, APOE3, and APOE4. Most people carry two copies — one from each parent — giving rise to genotypes like APOE3/3 (the most common), APOE3/4, or APOE4/4.

The APOE4 variant is the most well-studied genetic risk factor for late-onset Alzheimer’s disease. Carrying one copy of APOE4 (APOE3/4) increases lifetime dementia risk by approximately two to three times. Carrying two copies (APOE4/4) increases it by eight to twelve times. Around 25% of the population carries at least one APOE4 allele — meaning this is not a rare concern.

APOE4 influences Alzheimer’s risk through several mechanisms: it impairs the clearance of amyloid-beta from the brain, disrupts lipid metabolism in neurons, promotes neuroinflammation, and reduces mitochondrial efficiency in brain cells. These are the same pathways that dietary intervention can meaningfully modulate — which is why the Norgren et al. findings matter.

What the JAMA Network Open study found

The study followed over 2,000 older adults in Sweden, tracking dietary patterns — specifically meat consumption — against cognitive trajectories and dementia incidence over time, stratified by APOE genotype.

In the overall population, higher meat consumption showed no significant association with cognitive health — consistent with the existing mixed evidence base. But when the researchers stratified by genotype, a clear pattern emerged.

In individuals carrying APOE3/4 or APOE4/4 genotypes, higher total meat consumption was associated with significantly slower cognitive decline and a meaningfully lower risk of dementia. The effect was most pronounced for unprocessed red meat — lamb, beef, pork — and was not replicated for processed meat (bacon, sausages, cured meats), which showed no protective association regardless of genotype.

For APOE3/3 individuals — those without an APOE4 allele — no significant association between meat consumption and cognitive outcomes was observed. The protective relationship was specific to APOE4 carriers.

Why might this be?

The authors propose several mechanistic explanations, and admittedly the full picture is not yet established — this is a relatively new area of genotype-specific nutrition research.

APOE4 impairs neuronal lipid metabolism. Neurons in APOE4 carriers are less efficient at synthesising and recycling cholesterol and phospholipids — the structural fats that form myelin sheaths and synaptic membranes. Unprocessed meat provides creatine, carnitine, zinc, and complete protein — nutrients that support mitochondrial energy production in neurons and may partially compensate for the metabolic inefficiency that APOE4 introduces.

APOE4 also increases neuroinflammatory signalling. The anti-inflammatory fatty acid profile of unprocessed meat (when raised on pasture and eaten as part of a diverse diet) may provide a modest counterbalance — whereas processed meat, with its higher sodium, nitrite content, and oxidised lipid profile, offers no such benefit and may worsen the inflammatory environment.

There is also the creatine hypothesis. Creatine is found almost exclusively in animal muscle tissue. It is the primary substrate for the phosphocreatine system — the brain’s rapid energy buffer. APOE4 carriers show measurably reduced glucose metabolism in specific brain regions decades before any cognitive symptoms appear. Dietary creatine may partially buffer this energy deficit.

What this means if you are in perimenopause

Perimenopause is the window in which the interaction between oestrogen, APOE genotype, and brain health becomes most relevant. Oestrogen directly supports the mechanisms that APOE4 impairs: it promotes amyloid-beta clearance, reduces neuroinflammation, and supports mitochondrial efficiency in neurons. As oestrogen begins to fluctuate and decline in perimenopause, APOE4 carriers lose a layer of neuroprotection that may have been compensating for their genotype for decades.

The intersection of declining oestrogen and APOE4-related metabolic vulnerability is one reason researchers increasingly believe that perimenopause is the critical window for brain health intervention — not post-menopause, not later. The decisions made in your 40s about diet, sleep, movement, and stress regulation are shaping the neural environment your brain will inhabit at 70. This is the central argument of the brain fog post, and the Norgren et al. findings add a specific, genotype-dependent layer to it.

It is worth noting clearly: this study does not suggest that everyone should eat more meat, or that meat consumption prevents dementia. The findings are specific to unprocessed meat, specific to APOE4 carriers, and come with the standard limitations of observational dietary research — self-reported intake, potential confounders, and a predominantly older Swedish population. More research is needed, as the expert commentators at the Science Media Centre noted at publication.

What it does suggest is that personalised nutrition is not a trend. The same dietary choice — eating or not eating unprocessed red meat — has meaningfully different implications depending on your genetic background. Knowing your APOE status is increasingly relevant information for women navigating perimenopause.

What to do with this information

You do not need to know your APOE genotype to benefit from these findings. But if you are curious, consumer genomics tests (23andMe, AncestryDNA, and similar services) do report APOE status, and a growing number of functional medicine practitioners include it in routine testing.

If you carry APOE4 (or simply want to support brain health in perimenopause regardless of genotype), the evidence points toward a consistent set of dietary priorities:

Include good quality unprocessed protein — lamb, beef, eggs — alongside an abundance of plant diversity. The protective associations in the Norgren study were seen in the context of a diet that also included vegetables, wholegrains, and varied plant foods. Unprocessed meat as the centrepiece of an otherwise diverse, polyphenol-rich diet is very different from unprocessed meat in an otherwise impoverished one.

Minimise processed meat. The protective association was specific to unprocessed forms. Processed meat — with its nitrite content, oxidised lipid profile, and high sodium load — showed no protective effect in any genotype group and has established associations with colorectal cancer risk independent of this study.

Prioritise the methylation diet alongside protein quality. The methylation diet — leafy greens, cruciferous vegetables, eggs, legumes, berries — provides the methyl donors that support both epigenetic clock maintenance and, separately, homocysteine metabolism. Elevated homocysteine is an independent risk factor for neurodegeneration and is particularly relevant for APOE4 carriers, as APOE4 impairs the recycling of homocysteine more than other variants.

Lion’s Mane mushroom has the most robust clinical evidence base for supporting nerve growth factor (NGF) synthesis — the mechanism by which the brain maintains and forms neural connections. For APOE4 carriers in perimenopause, supporting NGF production is a meaningful and evidence-grounded complement to dietary strategy.

Personalised nutrition is not about finding a single optimal diet. It is about understanding the biological context in which your food choices land — and adjusting accordingly. The APOE gene is one piece of that context. It is a specific, actionable piece. And in perimenopause, when the stakes for brain health are at their highest, it is worth knowing about.

Key reference: Norgren J et al., “Meat Consumption and Cognitive Health by APOE Genotype” — JAMA Network Open, 19 March 2026. DOI: 10.1001/jamanetworkopen.2026.6489